Insights

Recent IPO Affinia Therapeutics recently went public and aims to raise up to $100 million in an IPO, indicating potential growth opportunities and a focus on expanding operations.

Expansion to Waltham The company recently expanded its offices to Waltham, Massachusetts, emphasizing a strategic move to establish a presence in a key biotech hub, presenting opportunities for collaboration and partnerships in the region.

Series B Funding Affinia Therapeutics secured $110 million in Series B funding, signifying strong investor confidence and financial stability, potentially opening avenues for partnership or investment opportunities.

Experienced Leadership Team The company's leadership team includes industry experts from reputable organizations like Novartis Gene Therapies and Editas Medicine, showcasing a wealth of experience that can be leveraged to build strategic partnerships and collaborations.

Innovative Gene Therapy Platform Affinia Therapeutics boasts a proprietary platform for gene therapy development, highlighting a unique technological advantage that could attract interest from biotech companies seeking innovative solutions for rare and prevalent diseases.

Affinia Therapeutics Tech Stack

Affinia Therapeutics uses 8 technology products and services including NetSuite, Microsoft Excel, Polyfill, and more. Explore Affinia Therapeutics's tech stack below.

  • NetSuite
    E-commerce
  • Microsoft Excel
    Editors
  • Polyfill
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • Python
    Programming Languages
  • Greenhouse
    Recruitment Marketing
  • Nginx
    Web Servers
  • Apache
    Web Servers

Media & News

Affinia Therapeutics's Email Address Formats

Affinia Therapeutics uses at least 1 format(s):
Affinia Therapeutics Email FormatsExamplePercentage
flast@affiniatx.comJDoe@affiniatx.com
94%
f-last@affiniatx.comJ-Doe@affiniatx.com
3%
fmiddlelast@affiniatx.comJMichaelDoe@affiniatx.com
1%
fmlast@affiniatx.comJMDoe@affiniatx.com
2%

Frequently Asked Questions

Where is Affinia Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Affinia Therapeutics's main headquarters is located at 43 Foundry Ste 120 Waltham, Massachusetts 02453 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Affinia Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Affinia Therapeutics is a publicly traded company; the company's stock symbol is AFTX.

What is Affinia Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Affinia Therapeutics's official website is affiniatx.com and has social profiles on LinkedIn.

How much revenue does Affinia Therapeutics generate?

Minus sign iconPlus sign icon
As of June 2024, Affinia Therapeutics's annual revenue reached $15M.

What is Affinia Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Affinia Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Affinia Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2024, Affinia Therapeutics has approximately 70 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: R. M.Chief Scientific Officer: C. A.Chief Operating Officer: R. J.. Explore Affinia Therapeutics's employee directory with LeadIQ.

What industry does Affinia Therapeutics belong to?

Minus sign iconPlus sign icon
Affinia Therapeutics operates in the Biotechnology Research industry.

What technology does Affinia Therapeutics use?

Minus sign iconPlus sign icon
Affinia Therapeutics's tech stack includes NetSuiteMicrosoft ExcelPolyfillMicrosoftPythonGreenhouseNginxApache.

What is Affinia Therapeutics's email format?

Minus sign iconPlus sign icon
Affinia Therapeutics's email format typically follows the pattern of . Find more Affinia Therapeutics email formats with LeadIQ.

How much funding has Affinia Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2024, Affinia Therapeutics has raised $110M in funding. The last funding round occurred on May 03, 2021.

When was Affinia Therapeutics founded?

Minus sign iconPlus sign icon
Affinia Therapeutics was founded in 2019.
Affinia Therapeutics

Affinia Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Affinia Therapeutics is an innovative gene therapy company focused on broadening the reach of gene therapy. Our proprietary Affinia Rationally-designed Therapies (ART) platform is created to address key limitations of conventional gene therapies, by developing novel capsids, novel promoters, and novel manufacturing approaches to developing gene therapies for rare and prevalent devastating diseases. We are backed by a strong syndicate of life science investors and have ambitious plans to have a dramatic impact on the lives of patients around the world. 

As an early employee you will play a key role in setting our culture and values. You will be working alongside the founding management team who have a track record of success in the industry. The pace of work is dynamic, fast and fun. 

Our brand new Site Includes:  State of the Art lab space & Equipment-
Healthy Cafe, Outdoor Patio, State of the Art Gym/Yoga Studio, Lounge ( Pool Table/ Golf Simulator ), Free/Plentiful Parking and More!

Join Us! 



Section iconCompany Overview

Headquarters
43 Foundry Ste 120 Waltham, Massachusetts 02453 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AFTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $110M

    Affinia Therapeutics has raised a total of $110M of funding over 2 rounds. Their latest funding round was raised on May 03, 2021.

  • $10M$50M

    Affinia Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $110M

    Affinia Therapeutics has raised a total of $110M of funding over 2 rounds. Their latest funding round was raised on May 03, 2021.

  • $10M$50M

    Affinia Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.